Reperfusion by endovascular thrombectomy and early cerebral edema in anterior circulation stroke: Results from the SITS-International Stroke Thrombectomy Registry.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 27 11 2023
pubmed: 25 5 2023
entrez: 25 5 2023
Statut: ppublish

Résumé

A large infarct and expanding cerebral edema (CED) due to a middle cerebral artery occlusion confers a 70% mortality unless treated surgically. There is still conflicting evidence whether reperfusion is associated with a lower risk for CED in acute ischemic stroke. To investigate the association of reperfusion with development of early CED after stroke thrombectomy. From the SITS-International Stroke Thrombectomy Registry, we selected patients with occlusion of the intracranial internal carotid or middle cerebral artery (M1 or M2). Successful reperfusion was defined as mTICI ⩾ 2b. Primary outcome was moderate or severe CED, defined as focal brain swelling ⩾1/3 of the hemisphere on imaging scans at 24 h. We used regression methods while adjusting for baseline variables. Effect modification by severe early neurological deficits, as indicators of large infarct at baseline and at 24 h, were explored. In total, 4640 patients, median age 70 years and median National Institutes of Health Stroke Score (NIHSS) 16, were included. Of these, 86% had successful reperfusion. Moderate or severe CED was less frequent among patients who had reperfusion compared to patients without reperfusion: 12.5% versus 29.6%, p < 0.05, crude risk ratio (RR) 0.42 (95% confidence interval (CI): 0.37-0.49), and adjusted RR 0.50 (95% CI: 0.44-0.57). Analysis of effect modification indicated that severe neurological deficits weakened the association between reperfusion and lower risk of CED. The RR reduction was less favorable in patients with severe neurological deficits, defined as NIHSS score 15 or more at baseline and at 24 h, used as an indicator for larger infarction. In patients with large artery anterior circulation occlusion stroke who underwent thrombectomy, successful reperfusion was associated with approximately 50% lower risk for early CED. Severe neurological deficit at baseline seems to be a predictor for moderate or severe CED also in patients with successful reperfusion by thrombectomy.

Sections du résumé

BACKGROUND UNASSIGNED
A large infarct and expanding cerebral edema (CED) due to a middle cerebral artery occlusion confers a 70% mortality unless treated surgically. There is still conflicting evidence whether reperfusion is associated with a lower risk for CED in acute ischemic stroke.
AIM UNASSIGNED
To investigate the association of reperfusion with development of early CED after stroke thrombectomy.
METHODS UNASSIGNED
From the SITS-International Stroke Thrombectomy Registry, we selected patients with occlusion of the intracranial internal carotid or middle cerebral artery (M1 or M2). Successful reperfusion was defined as mTICI ⩾ 2b. Primary outcome was moderate or severe CED, defined as focal brain swelling ⩾1/3 of the hemisphere on imaging scans at 24 h. We used regression methods while adjusting for baseline variables. Effect modification by severe early neurological deficits, as indicators of large infarct at baseline and at 24 h, were explored.
RESULTS UNASSIGNED
In total, 4640 patients, median age 70 years and median National Institutes of Health Stroke Score (NIHSS) 16, were included. Of these, 86% had successful reperfusion. Moderate or severe CED was less frequent among patients who had reperfusion compared to patients without reperfusion: 12.5% versus 29.6%, p < 0.05, crude risk ratio (RR) 0.42 (95% confidence interval (CI): 0.37-0.49), and adjusted RR 0.50 (95% CI: 0.44-0.57). Analysis of effect modification indicated that severe neurological deficits weakened the association between reperfusion and lower risk of CED. The RR reduction was less favorable in patients with severe neurological deficits, defined as NIHSS score 15 or more at baseline and at 24 h, used as an indicator for larger infarction.
CONCLUSION UNASSIGNED
In patients with large artery anterior circulation occlusion stroke who underwent thrombectomy, successful reperfusion was associated with approximately 50% lower risk for early CED. Severe neurological deficit at baseline seems to be a predictor for moderate or severe CED also in patients with successful reperfusion by thrombectomy.

Identifiants

pubmed: 37226337
doi: 10.1177/17474930231180451
pmc: PMC10676032
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1193-1201

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: N.A. reports that he is chair of SITS International and received speaker honorarium from Boehringer Ingelheim. S-Y.C. is an employee of Biogen and owns stock in Biogen. N.T. was an employee of Biogen at the time of the study and owns stock in Biogen.

Références

J Stroke. 2023 Jan;25(1):101-110
pubmed: 36470246
Stroke. 2001 Feb;32(2):438-41
pubmed: 11157179
J Cereb Blood Flow Metab. 2020 Feb;40(2):437-445
pubmed: 30628850
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
J Cereb Blood Flow Metab. 2016 Mar;36(3):513-38
pubmed: 26661240
Lancet Neurol. 2009 Oct;8(10):949-58
pubmed: 19747656
N Engl J Med. 2023 Apr 6;388(14):1272-1283
pubmed: 36762852
Int J Stroke. 2013 Oct;8(7):529-34
pubmed: 22405327
Stroke. 2022 Aug;53(8):2628-2636
pubmed: 35450438
N Engl J Med. 2023 Apr 6;388(14):1326-1328
pubmed: 36762847
Lancet. 2007 Jan 27;369(9558):275-82
pubmed: 17258667
Int J Stroke. 2015 Feb;10(2):143-52
pubmed: 25598025
N Engl J Med. 2022 Apr 7;386(14):1303-1313
pubmed: 35138767
Crit Care Med. 2003 Jan;31(1):272-7
pubmed: 12545028
Arch Neurol. 1996 Apr;53(4):309-15
pubmed: 8929152
Stroke. 2017 Sep;48(9):2464-2471
pubmed: 28775140
Stroke. 2021 Nov;52(11):3450-3458
pubmed: 34384229
Stroke. 2014 Dec;45(12):3643-8
pubmed: 25336512
Neurology. 2012 Sep 25;79(13 Suppl 1):S52-7
pubmed: 23008413
N Engl J Med. 2023 Apr 6;388(14):1259-1271
pubmed: 36762865
Stroke. 2020 Jan;51(1):216-223
pubmed: 31818228
J Intern Med. 2021 Sep;290(3):646-654
pubmed: 33999451
Lancet Neurol. 2007 Mar;6(3):215-22
pubmed: 17303527
J Cereb Blood Flow Metab. 2018 Oct;38(10):1807-1817
pubmed: 28731381
J Neurointerv Surg. 2019 Oct;11(10):994-998
pubmed: 30798266
JAMA Neurol. 2018 Apr 1;75(4):453-461
pubmed: 29365017
J Neurointerv Surg. 2017 Apr;9(4):394-398
pubmed: 27036980
J Intern Med. 2017 Mar;281(3):273-283
pubmed: 27862464
Neurology. 2021 Aug 24;97(8):e765-e776
pubmed: 34088873
Stroke. 2013 Sep;44(9):2650-63
pubmed: 23920012

Auteurs

Magnus Thorén (M)

Stroke Research Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurology, Danderyd Hospital, Stockholm, Sweden.

Irene Escudero-Martínez (I)

Department of Neurology, Hospital Universitari i Politécnic La Fe, Valencia, Spain.
Neurovascular Research Laboratory, Instituto de Biomedicina de Sevilla (IBiS), Sevilla, Spain.

Tomas Andersson (T)

Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Shih-Yin Chen (SY)

Value & Access, Biogen, Cambridge, MA, USA.

Nicole Tsao (N)

Global Medical Affairs, Biogen, Cambridge, MA, USA.

Dheeraj Khurana (D)

Department of Neurology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Simone Beretta (S)

Department of Neurology and Stroke Unit, San Gerardo Hospital, Monza, Italy.

Andre Peeters (A)

Department of Neurology and Stroke Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Georgios Tsivgoulis (G)

Second Department of Neurology, National & Kapodistrian University of Athens, Athens, Greece.

Christine Roffe (C)

Stroke Research, Keele University, Stoke-on-Trent, UK.

Niaz Ahmed (N)

Stroke Research Unit, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH